Slides
Page 1
Celldex therapeutics CDX - 0159 Phase 1b Study Results in Cold Contact Urticaria and Symptomatic Dermographism EAACI 2021 July 12 , 2021
Loading workspace
Celldex therapeutics CDX - 0159 Phase 1b Study Results in Cold Contact Urticaria and Symptomatic Dermographism EAACI 2021 July 12 , 2021
Your watchlist and earnings event details are available after you sign in.